FDA Inspection
IndeCon, Inc.IndeCon, Inc. – FDA Inspection, Nov 22, 2016
Record Details
This FDA Inspection record concerns IndeCon, Inc., with an inspection on November 22, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Person
- Yaw O. Osei (Issuing Officer)
View Company Profile
ID · 81c813a0-59c5-4f9b-a601-bdf071cef1cf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 998132
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 1271.265(f)Return to inventory--procedures
- 21 CFR 1271.190(d)(1)Procedures for cleaning, sanitation
- 21 CFR 1271.320(a)Procedures re complaints
- 21 CFR 1271.265(e)Procedures and release criteria
Full citation text and observation details available on the Dashboard.
Other FDA inspections of IndeCon, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 12, 2024 | VAI | Dallas District Office | Human Cellular, Tissue, and Gene Therapies |
| May 29, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for IndeCon, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.